Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities
Abstract Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are possible determinants of disease sever...
Main Authors: | Ana Emília Goulart Lemos, Gabriela Ribeiro Silva, Etel Rodrigues Pereira Gimba, Aline da Rocha Matos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14067 |
Similar Items
-
Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group
by: Clarissa Baldotto, et al.
Published: (2020-06-01) -
Clinical Characteristics and Outcomes of COVID-19 in West Virginia
by: Sijin Wen, et al.
Published: (2021-05-01) -
COVID19 biomarkers: What did we learn from systematic reviews?
by: Sabina Semiz
Published: (2022-12-01) -
The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2: A systematic review and meta‐analysis
by: Samuel Seidu, et al.
Published: (2021-01-01) -
COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults
by: Laura Ziuzia-Januszewska, et al.
Published: (2022-07-01)